Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CE22-003, Rigorously Evaluating Programs and Policies To Prevent Child Sexual Abuse (CSA); Amended Notice of Meeting, 12710 [2022-04681]

Download as PDF khammond on DSKJM1Z7X2PROD with NOTICES 12710 Federal Register / Vol. 87, No. 44 / Monday, March 7, 2022 / Notices Purpose: The establishment and formation of the HEW is to provide input to the ACD, CDC on agency-wide activities related to the scope and implementation of CDC’s CORE (an acronym for C-cultivate comprehensive health equity science, O-optimize interventions, R-reinforce and expand robust partnerships, and E-enhance capacity and workforce diversity and inclusion) strategy around health equity. The HEW membership will be comprised of approximately 15 members. It will be chaired by two current ACD, CDC Special Government Employees. HEW co-chairs will present their findings, observations, and work products at one or more ACD, CDC meetings for discussion, deliberation, and decisions (final recommendations to CDC). Nomination Criteria: HEW members will serve terms ranging from six months to one year and be required to attend HEW meetings approximately 1– 2 times per month (virtually or inperson), and contribute time in between meetings for research, consultation, discussion, and writing assignments. Nominations are being sought for individuals who have the expertise and qualifications necessary to contribute to the accomplishments of the committee’s/workgroup’s objectives. Nominees will be selected based on expertise in the fields of health equity; public health science and practice; public health policy development, analysis, and implementation. To ensure a diverse workgroup composition, nominees with front line and field experience at the local, state, tribal and territorial levels are encouraged to apply. This includes nominees with experience working for, and with, community-based organizations and other non-profit organizations. Federal employees will not be considered for membership. Selection of members is based on candidates’ qualifications to contribute to the accomplishment of the HEW’s objectives. HHS policy stipulates that membership be balanced in terms of points of view represented and the workgroup’s function. Appointments shall be made without discrimination based on age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens and cannot be fulltime employees of the U.S. Government. Current participation on federal workgroups or prior experience serving on a federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive VerDate Sep<11>2014 17:50 Mar 04, 2022 Jkt 256001 individual service on advisory committees and multiple committee memberships. Interested candidates should submit the following items: D A one-half to one-page cover letter that includes your understanding of, and commitment to, the time and work necessary; one to two sentences on your background and experience; and one to two sentences on the skills/perspective you would bring to the HEW. D Current curriculum vitae which highlights the experience and work history being sought relevant to the criteria set forth above, including complete contact information (telephone numbers, mailing address, email address). Nominations may be submitted by the candidate him or herself, or by the person/organization recommending the candidate. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. The meeting is being amended to change the meeting date and should read as follows: CE22–003, Rigorously Evaluating Programs and Policies to Prevent Child Sexual Abuse (CSA): April 19, 2022. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific Review Officer, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop S106–9, Atlanta, Georgia 30341, Telephone (404) 639–6473, AWilkes@ cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–04681 Filed 3–4–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [FR Doc. 2022–04690 Filed 3–4–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE22–003, Rigorously Evaluating Programs and Policies To Prevent Child Sexual Abuse (CSA); Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE22– 003, Rigorously Evaluating Programs and Policies to Prevent Child Sexual Abuse (CSA), April 19–20, 2022, 8:30 a.m., EDT–5:30 p.m., EDT, Web Conference, in the original FRN. The meeting was published in the Federal Register on January 14, 2022, Volume 87, Number 10, page 2439. PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–CE22– 002, Grants To Support New Investigators in Conducting Research Related To Preventing Interpersonal Violence Impacting Children and Youth; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA– CE22–002, Grants to Support New Investigators in Conducting Research Related to Preventing Interpersonal Violence Impacting Children and Youth, March 8–9, 2022, 8:30 a.m., EDT–5:30 p.m., EDT, Web Conference, in the original FRN. The meeting was published in the Federal Register on January 5, 2022, Volume 87, Number 3, page 460. The meeting is being amended to change the meeting date and should read as follows: RFA–CE22–002, Grants to Support New Investigators in Conducting Research Related to Preventing E:\FR\FM\07MRN1.SGM 07MRN1

Agencies

[Federal Register Volume 87, Number 44 (Monday, March 7, 2022)]
[Notices]
[Page 12710]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04681]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--CE22-003, Rigorously Evaluating Programs and 
Policies To Prevent Child Sexual Abuse (CSA); Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--CE22-003, Rigorously Evaluating Programs and Policies to Prevent 
Child Sexual Abuse (CSA), April 19-20, 2022, 8:30 a.m., EDT-5:30 p.m., 
EDT, Web Conference, in the original FRN. The meeting was published in 
the Federal Register on January 14, 2022, Volume 87, Number 10, page 
2439.
    The meeting is being amended to change the meeting date and should 
read as follows:
    CE22-003, Rigorously Evaluating Programs and Policies to Prevent 
Child Sexual Abuse (CSA): April 19, 2022.
    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific 
Review Officer, National Center for Injury Prevention and Control, CDC, 
4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341, 
Telephone (404) 639-6473, [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-04681 Filed 3-4-22; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.